ZeptoMetrix® Assay Development Partner Solutions
ZeptoMetrix® partners with assay developers across all stages of assay development, from concept and design to commercialization.
Receive your quote directly from the manufacturer.
ZeptoMetrix® is a trusted partner for diagnostic assay manufacturers, providing comprehensive support across the full assay development lifecycle. Our scientists work with assay developers at every stage, from concept and feasibility to analytical validation, scale-up, and commercial launch. This ensures a high-quality, reliable, and efficient product.
ZeptoMetrix offers a diverse portfolio to support IVD development excellence. This includes microorganism sourcing, custom controls, validation materials, recombinant generation, antibodies and reagents for immunoassays, and proficiency testing surveys. With expertise across bacteriology, virology, molecular biology, immunology, mycology, and parasitology, our PhD-level scientists and BSL-2 and BSL-3 labs provide technical depth and innovation for high-complexity and point-of-care assays.
Our global distribution network, regulatory compliance with ISO 13485:2016, IVDD, and IVDR, and longstanding partnerships with more than 25 major diagnostic manufacturers ensure reliable supply, rapid scale-up, and trusted support for assay development projects worldwide.
Accelerate your assay development with ZeptoMetrix
Navigating the complexities of assay development can be challenging, especially when balancing innovation, regulatory demands, and time-to-market pressures. Whether you are in the early stages of designing a novel molecular test or preparing for scale-up and commercialization, having access to reliable expertise and resources can make a significant difference.
Find out how with over 20 years of experience and a library of more than 1,200 microorganisms, ZeptoMetrix® offers a broad portfolio and collaborative approach that supports assay developers at various stages — from initial feasibility through to analytical validation, manufacturing, and beyond.
Key collaboration enables rapid respiratory testing at the point of care
Heather Danks, Chief Technology Officer at LEX Diagnostics, highlights a key partnership with ZeptoMetrix while developing an ultra-fast thermocycling PCR device for rapid Influenza & SARS-CoV-2 testing. Designed for speed, affordability, and usability, the device enables efficient point-of-care diagnostics. ZeptoMetrix has provided vital support in creating custom controls, working closely with LEX Diagnostics to tailor products to the LEX system. Alongside launching their first product, LEX Diagnostics aims to expand their test menu, setting new standards in patient care.
This video was filmed at ESCMID Global 2025, Vienna, Austria.
